BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23175273)

  • 21. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Morgan RE; van Staden CJ; Chen Y; Kalyanaraman N; Kalanzi J; Dunn RT; Afshari CA; Hamadeh HK
    Toxicol Sci; 2013 Nov; 136(1):216-41. PubMed ID: 23956101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of high basolateral bile salt efflux to the lack of hepatotoxicity in rat in response to drugs inducing cholestasis in human.
    Jemnitz K; Veres Z; Vereczkey L
    Toxicol Sci; 2010 May; 115(1):80-8. PubMed ID: 20147439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological concentrations of unconjugated bilirubin prevent oxidative stress-induced hepatocanalicular dysfunction and cholestasis.
    Basiglio CL; Toledo FD; Boaglio AC; Arriaga SM; Ochoa JE; Sánchez Pozzi EJ; Mottino AD; Roma MG
    Arch Toxicol; 2014 Feb; 88(2):501-14. PubMed ID: 24306262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells.
    Sharanek A; Azzi PB; Al-Attrache H; Savary CC; Humbert L; Rainteau D; Guguen-Guillouzo C; Guillouzo A
    Toxicol Sci; 2014 Sep; 141(1):244-53. PubMed ID: 24973091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
    Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
    Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
    Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
    Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
    Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
    Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
    Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17β-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C.
    Boaglio AC; Zucchetti AE; Sánchez Pozzi EJ; Pellegrino JM; Ochoa JE; Mottino AD; Vore M; Crocenzi FA; Roma MG
    Hepatology; 2010 Oct; 52(4):1465-76. PubMed ID: 20815017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy.
    Vallejo M; Briz O; Serrano MA; Monte MJ; Marin JJ
    J Hepatol; 2006 Jun; 44(6):1150-7. PubMed ID: 16458994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor-mediated regulation of Bsep and Mrp2.
    Liu B; Li Y; Ji H; Lu H; Li H; Shi Y
    Can J Physiol Pharmacol; 2017 Feb; 95(2):215-223. PubMed ID: 28051334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells.
    Harris MJ; Kagawa T; Dawson PA; Arias IM
    J Gastroenterol Hepatol; 2004 Jul; 19(7):819-25. PubMed ID: 15209631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes.
    Bachour-El Azzi P; Sharanek A; Burban A; Li R; Guével RL; Abdel-Razzak Z; Stieger B; Guguen-Guillouzo C; Guillouzo A
    Toxicol Sci; 2015 May; 145(1):157-68. PubMed ID: 25690737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes.
    Rippin SJ; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2001 Apr; 33(4):776-82. PubMed ID: 11283839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
    Funk C; Ponelle C; Scheuermann G; Pantze M
    Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.
    Lang C; Meier Y; Stieger B; Beuers U; Lang T; Kerb R; Kullak-Ublick GA; Meier PJ; Pauli-Magnus C
    Pharmacogenet Genomics; 2007 Jan; 17(1):47-60. PubMed ID: 17264802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2.
    Mano Y; Usui T; Kamimura H
    Biopharm Drug Dispos; 2007 Jan; 28(1):13-8. PubMed ID: 17061295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
    Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
    J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis.
    Stieger B
    Drug Metab Rev; 2010 Aug; 42(3):437-45. PubMed ID: 20028269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.